Annual Total Expenses
$28.35 M
-$6.45 M-18.54%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual total expenses is $28.35 million, with the most recent change of -$6.45 million (-18.54%) on April 30, 2024.
- During the last 3 years, IPA annual total expenses has risen by +$11.47 million (+67.94%).
- IPA annual total expenses is now -18.54% below its all-time high of $34.80 million, reached on April 30, 2023.
Performance
IPA Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$6.55 M
-$670.00 K-9.28%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly total expenses is $6.55 million, with the most recent change of -$670.00 thousand (-9.28%) on October 31, 2024.
- Over the past year, IPA quarterly total expenses has dropped by -$670.00 thousand (-9.28%).
- IPA quarterly total expenses is now -41.78% below its all-time high of $11.25 million, reached on July 31, 2022.
Performance
IPA Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
IPA Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.5% | -9.3% |
| 3 y3 years | +67.9% | -9.3% |
| 5 y5 years | +117.8% | -9.3% |
IPA Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.5% | +67.9% | -41.8% | at low |
| 5 y | 5-year | -18.5% | +117.8% | -41.8% | +132.3% |
| alltime | all time | -18.5% | >+9999.0% | -41.8% | +7386.3% |
ImmunoPrecise Antibodies Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $6.55 M(-9.3%) |
| Jul 2024 | - | $7.22 M(-1.7%) |
| Apr 2024 | $28.35 M(-18.5%) | $7.35 M(+3.8%) |
| Jan 2024 | - | $7.08 M(+7.4%) |
| Oct 2023 | - | $6.59 M(-6.9%) |
| Jul 2023 | - | $7.08 M(+5.9%) |
| Apr 2023 | $34.80 M(+21.2%) | $6.68 M(-7.4%) |
| Jan 2023 | - | $7.21 M(-26.1%) |
| Oct 2022 | - | $9.76 M(-13.2%) |
| Jul 2022 | - | $11.25 M(+50.0%) |
| Apr 2022 | $28.72 M(+70.2%) | $7.50 M(+4.6%) |
| Jan 2022 | - | $7.17 M(-4.0%) |
| Oct 2021 | - | $7.47 M(+15.2%) |
| Jul 2021 | - | $6.48 M(+11.1%) |
| Apr 2021 | $16.88 M(+26.0%) | $5.83 M(+37.3%) |
| Jan 2021 | - | $4.25 M(+3.8%) |
| Oct 2020 | - | $4.09 M(+45.2%) |
| Jul 2020 | - | $2.82 M(-27.0%) |
| Apr 2020 | $13.40 M(+2.9%) | $3.87 M(+20.2%) |
| Jan 2020 | - | $3.22 M(+2.5%) |
| Oct 2019 | - | $3.14 M(-0.4%) |
| Jul 2019 | - | $3.15 M(-30.8%) |
| Apr 2019 | $13.02 M(+62.8%) | $4.55 M(+71.8%) |
| Jan 2019 | - | $2.65 M(-10.4%) |
| Oct 2018 | - | $2.96 M(+4.0%) |
| Jul 2018 | - | $2.84 M(-2.5%) |
| Apr 2018 | $8.00 M(+166.4%) | $2.91 M(+31.6%) |
| Jan 2018 | - | $2.22 M(+23.6%) |
| Oct 2017 | - | $1.79 M(+63.9%) |
| Jul 2017 | - | $1.09 M(-10.5%) |
| Apr 2017 | $3.00 M(>+9900.0%) | $1.22 M(+48.7%) |
| Jan 2017 | - | $822.20 K(+7730.5%) |
| Sep 2016 | - | $10.50 K(+45.8%) |
| Jun 2016 | - | $7200.00(+132.3%) |
| Mar 2016 | - | $3100.00(-72.3%) |
| Dec 2015 | $5400.00(-83.8%) | - |
| Dec 2015 | - | $11.20 K(+409.1%) |
| Sep 2015 | - | $2200.00(-132.8%) |
| Jun 2015 | - | -$6700.00(+204.5%) |
| Mar 2015 | - | -$2200.00(-81.0%) |
| Dec 2014 | $33.40 K(-61.6%) | - |
| Dec 2014 | - | -$11.60 K(-143.1%) |
| Sep 2014 | - | $26.90 K(+1482.4%) |
| Jun 2014 | - | $1700.00(-90.1%) |
| Mar 2014 | - | $17.10 K(-52.5%) |
| Dec 2013 | $87.00 K(+7.1%) | - |
| Dec 2013 | - | $36.00 K(+73.9%) |
| Sep 2013 | - | $20.70 K(+69.7%) |
| Jun 2013 | - | $12.20 K(-30.7%) |
| Mar 2013 | - | $17.60 K(-49.4%) |
| Dec 2012 | $81.20 K(-61.4%) | - |
| Dec 2012 | - | $34.80 K(+89.1%) |
| Sep 2012 | - | $18.40 K(+187.5%) |
| Jun 2012 | - | $6400.00(-70.6%) |
| Mar 2012 | - | $21.80 K(-51.3%) |
| Dec 2011 | $210.10 K(-17.1%) | - |
| Dec 2011 | - | $44.80 K(-30.7%) |
| Sep 2011 | - | $64.60 K(+2.7%) |
| Jun 2011 | - | $62.90 K(>+9900.0%) |
| Mar 2011 | - | $500.00(-99.5%) |
| Dec 2010 | $253.50 K | - |
| Dec 2010 | - | $97.00 K(+99.2%) |
| Sep 2010 | - | $48.70 K(+6857.1%) |
| Jun 2010 | - | $700.00(-98.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $59.90 K(-38.8%) |
| Dec 2009 | $236.50 K(-36.2%) | - |
| Dec 2009 | - | $97.80 K(+98.0%) |
| Sep 2009 | - | $49.40 K(+25.1%) |
| Jun 2009 | - | $39.50 K(-24.5%) |
| Mar 2009 | - | $52.30 K(-68.2%) |
| Dec 2008 | $370.70 K(-35.6%) | - |
| Dec 2008 | - | $164.50 K(+183.1%) |
| Sep 2008 | - | $58.10 K(-17.7%) |
| Jun 2008 | - | $70.60 K(+14.2%) |
| Mar 2008 | - | $61.80 K(-86.6%) |
| Dec 2007 | $575.80 K(+175.2%) | - |
| Dec 2007 | - | $460.40 K(+946.4%) |
| Sep 2007 | - | $44.00 K(-21.6%) |
| Jun 2007 | - | $56.10 K(+15.0%) |
| Mar 2007 | - | $48.80 K(-154.3%) |
| Dec 2006 | $209.20 K(+23.3%) | - |
| Dec 2006 | - | -$89.90 K(-358.3%) |
| Sep 2006 | - | $34.80 K(-83.9%) |
| Jun 2006 | - | $215.90 K(+325.8%) |
| Mar 2006 | - | $50.70 K(+13.2%) |
| Dec 2005 | $169.70 K(+10.1%) | - |
| Dec 2005 | - | $44.80 K(+78.5%) |
| Sep 2005 | - | $25.10 K(-36.8%) |
| Jun 2005 | - | $39.70 K(-76.3%) |
| Mar 2005 | - | $167.70 K(+419.2%) |
| Dec 2004 | $154.10 K(-30.2%) | - |
| Jun 2004 | - | $32.30 K(-25.1%) |
| Mar 2004 | - | $43.10 K(-70.5%) |
| Dec 2003 | $220.80 K(+119.7%) | - |
| Dec 2003 | - | $146.30 K(+600.0%) |
| Sep 2003 | - | $20.90 K(-39.8%) |
| Jun 2003 | - | $34.70 K(+35.0%) |
| Mar 2003 | - | $25.70 K(+21.8%) |
| Dec 2002 | $100.50 K(-19.9%) | - |
| Dec 2002 | - | $21.10 K(+2.4%) |
| Sep 2002 | - | $20.60 K(-39.6%) |
| Jun 2002 | - | $34.10 K(+37.5%) |
| Mar 2002 | - | $24.80 K(-4233.3%) |
| Dec 2001 | $125.50 K(+25.1%) | - |
| Dec 2001 | - | -$600.00(-101.1%) |
| Sep 2001 | - | $54.00 K(-25.6%) |
| Jun 2001 | - | $72.60 K(+181.4%) |
| Mar 2001 | - | $25.80 K(-6.5%) |
| Dec 2000 | $100.30 K(-19.0%) | - |
| Dec 2000 | - | $27.60 K(+23.2%) |
| Sep 2000 | - | $22.40 K(-13.2%) |
| Jun 2000 | - | $25.80 K(+6.2%) |
| Mar 2000 | - | $24.30 K(-5.8%) |
| Dec 1999 | $123.80 K(-20.9%) | - |
| Dec 1999 | - | $25.80 K(-0.8%) |
| Sep 1999 | - | $26.00 K(-28.6%) |
| Jun 1999 | - | $36.40 K(+2.8%) |
| Mar 1999 | - | $35.40 K(-23.9%) |
| Dec 1998 | $156.50 K(-22.3%) | - |
| Dec 1998 | - | $46.50 K(+45.3%) |
| Sep 1998 | - | $32.00 K(-25.9%) |
| Jun 1998 | - | $43.20 K(+25.6%) |
| Mar 1998 | - | $34.40 K(-32.7%) |
| Dec 1997 | $201.50 K(+20.4%) | - |
| Dec 1997 | - | $51.10 K(+38.1%) |
| Sep 1997 | - | $37.00 K(-53.5%) |
| Jun 1997 | - | $79.50 K(+138.0%) |
| Mar 1997 | - | $33.40 K |
| Dec 1996 | $167.30 K | - |
FAQ
- What is ImmunoPrecise Antibodies annual total expenses?
- What is the all time high annual total expenses for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual total expenses year-on-year change?
- What is ImmunoPrecise Antibodies quarterly total expenses?
- What is the all time high quarterly total expenses for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly total expenses year-on-year change?
What is ImmunoPrecise Antibodies annual total expenses?
The current annual total expenses of IPA is $28.35 M
What is the all time high annual total expenses for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual total expenses is $34.80 M
What is ImmunoPrecise Antibodies annual total expenses year-on-year change?
Over the past year, IPA annual total expenses has changed by -$6.45 M (-18.54%)
What is ImmunoPrecise Antibodies quarterly total expenses?
The current quarterly total expenses of IPA is $6.55 M
What is the all time high quarterly total expenses for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly total expenses is $11.25 M
What is ImmunoPrecise Antibodies quarterly total expenses year-on-year change?
Over the past year, IPA quarterly total expenses has changed by -$670.00 K (-9.28%)